The weakness in patients with LEMS usually is opposite in distribution to myasthenia. Limb weakness is a prominent symptom. Over 70% of patients complain of dry mouth (from impaired release of acetylcholine in autonomic fibers)and 50% are impotent. Ptosis and ophthalmoparesis are rare.
Viagra professional
The cause of LEMS is impaired release of acetylcholine from the pre-synaptic terminal. The normal release of acetylcholine containing vesicles from the presynaptic terminal requires inward moving calcium ions associated with membrane depolarization to bind with a calcium receptor triggering release of the vesicle into the synaptic space. Antibodies to the voltage gated calcium channel receptors appear to be the pathogenic mechanism for LEMS.
LEMS occurs as an autoimmune disease as well as a paraneoplastic disorder. It is frequently associated with small cell carcinoma of the lung but rarely is associated with neuroendocrine carcinoma. In LEMS associated with small cell carcinoma of the lung, the cancerous cells have structural homology or identity with neural autoantigens to elicit autoimmunity. Antibodies to the VGCC are specific for LEMS and are rarely found in other paraneoplastic disorders.
Propecia 5 mg online
Anti VGCC antibodies are of two types N and P/Q. Some reports have suggested a higher frequency of autonomic symptoms with the presence of particular subsets (N-type VGCCs occur more often in parasympathetic neurons). One study showed and excess of Q type autoantibodies in patients with autonomic symptoms 7 but another study showed no predominance of any subtype in these patients. However, over 93% of patients show elevated P/Q VGCC antibodies.
Treatment for LEMS may be successful by removing the antibody 4,8. Others have found success in plasmapheresis and intravenous immunoglobulin. A therapy that is directly enhances release of acetylcholine vesicles, diaminopyridine, has also shown success.
Jun 16
Recent Comments